Surgically debulked malignant pleural mesothelioma: Results and prognostic factors

被引：0
作者：
Harvey I. Pass
Karen Kranda
Barbara K. Temeck
Irwin Feuerstein
Seth M. Steinberg
机构：
[1] NCI/NIH,From the Thoracic Oncology Section, Surgery Branch
[2] Clinical Center,Radiology Department
[3] National Institutes of Health,the Biostatistics and Data Management Section
[4] National Cancer Institute/National Institutes of Health,undefined
来源：
Annals of Surgical Oncology | 1997年 / 4卷
关键词：
Mesothelioma; Surgery; Prognostic factors; Debulking;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: We analyzed morbidity and mortality, sites of recurrence, and possible prognostic factors in 95 (78 male, 17 female) patients with MPM on phase I–III trials since 1990. A debulking resection to a requisite, residual tumor thickness of ≤ 5 mm was required for inclusion.
引用
收藏
页码：215 / 222
页数：7
相关论文
共 20 条
[1]  
Pass HW(1995)A proposed new international TNM staging system for malignant pleural mesothelioma Chest 108 1122-8
[2]  
Temeck BK(1995)A phase II trial investigating primary immunochemotherapy for malignant pleural mesothelioma and the feasibility of adjuvant immunochemotherapy after maximal cytoreduction Ann Surg Oncol 2 214-20
[3]  
Kranda K(1958)Non-parametric estimation from incomplete observation J Am Stat Assoc 53 457-81
[4]  
Steinberg SM(1966)Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chem Rep 50 163-70
[5]  
Pass HI(1972)Regression models and lifetables J R Stat Soc 34 187-202
[6]  
Kaplan EL(1954)A distribution-free K-sample test against ordered alternatives Biometrika 41 133-45
[7]  
Meier P(1995)Esophagopleural fistula: a complication of photodynamic therapy South Med J 88 271-3
[8]  
Mantel N(1991)The role of extrapleural pneumonectomy in malignant pleural mesothelioma J Thorac Cardiovasc Surg 102 1-9
[9]  
Cox D(1993)Malignant pleural mesothelioma Curr Probl Surg 30 921-1020
[10]  
Jonckheere AR(1993)Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma J Clin Oncol 11 1172-8
12